You are currently browsing the archives for 9 May 2018.
Displaying 1 entry.

If the Court approve the Amended Plan.

At the meeting of affected creditors today, Alvarez & Marsal Canada Inc. , in its capability as the Court-appointed monitor, reported that 100 percent of the votes registered by the Angiotech Entities’ affected creditors were in favour of the Amended Strategy. To be approved, the Amended Strategy required approval by many in amount representing at least two-thirds of the total value of the affected creditors’ voting claims.. Angiotech’s affected lenders unanimously approve Second Amended and Restated Strategy of Compromise or Arrangement Angiotech Pharmaceuticals, Inc. today announced that the affected creditors of Angiotech and particular of its subsidiaries have unanimously approved the Second Amended and Restated Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities pursuant to the Businesses’ Creditors Arrangement Take action .